CE-Channel invites you to choose us for easy access to global partnerships, opening the doors to overseas markets for your business.
In today's globalized business landscape, forging partnerships across borders is essential for unlocking new opportunities and expanding into international markets. CE-Channel specializes in providing businesses with seamless access to a wide network of global partnerships, empowering them to thrive in overseas markets with ease.
With CE-Channel as your trusted partner, accessing global partnerships becomes effortless and straightforward. Our platform offers a range of tools and resources designed to simplify the partnership acquisition process, enabling businesses to quickly identify and connect with the most suitable partners to facilitate their expansion into overseas markets.
Through our advanced matchmaking algorithms and personalized approach, CE-Channel ensures that businesses are paired with partners who align perfectly with their specific goals and objectives. Whether you're looking to enter new markets, establish distribution channels, or explore strategic alliances, CE-Channel is committed to helping you achieve success in overseas markets.
Choose CE-Channel today and open the doors to overseas markets for your business. With CE-Channel leading the way, easy access to global partnerships is the key to unlocking your business's potential on the international stage!
品牌創始人 Founder
林懿慧 Ivy Lin
Taiwan +886 958213993 (We chat )
China : +86 188 2023 4680
E mail : ivy@ce-channel.com
Web : www.ce-channel.com
Office :
深圳市龙岗区龙翔大道4075号星知航大厦7B
7B, Xingzhihang Building, No. 4075 Longxiang Avenue, Longgang District, Shenzhen
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17